Phase I/II Dose Escalation Study of VELCADE® and Docetaxel in Patients With Advanced Androgen-Independent Prostate Cancer

Clinical trial NCT00064610 · COMPLETED

Trial details

NCT number: NCT00064610
Sponsor: Millennium Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Prostatic Neoplasms

Start date: 2002-12-01
Primary completion: 2004-12-01
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.